GlassScriptPhysician profile
David W Terreson
NPI 1417932120
$8,303.82
in general payments reported to CMS, 2019-2025
37 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,601 · 2020: $1,063 · 2021: $1,921 · 2022: $2,212 · 2023: $1,479 · 2024: $28.81.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,507.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,507.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,166.53 | 2019-2023 | |
| Amgen INC. | $1,030.66 | 2019-2023 | Repatha |
| Cvrx, INC. | $765.52 | 2021-2023 | Barostim Neo System |
| Novo Nordisk INC | $501.13 | 2021-2023 | Ozempic |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $494.59 | 2019-2024 | Lifevest |
| Janssen Pharmaceuticals, INC | $440.23 | 2019-2023 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $401.33 | 2019-2023 | Jardiance |
| Pfizer INC. | $392.25 | 2021-2023 | |
| Astrazeneca Pharmaceuticals LP | $359.74 | 2019-2023 | Brilinta |
| Amarin Pharma, INC. | $321.78 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $307.87 | 2019-2022 | |
| Abbott Laboratories | $294.79 | 2020-2023 | Mitraclip, Jeti Peripheral Catheter |
| Esperion Therapeutics, INC. | $218.60 | 2020-2022 | |
| Actelion Pharmaceuticals US, INC. | $198.01 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $197.87 | 2021-2022 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impulse Dynamics (USA) INC. | $180.99 | 2022-2023 | Optimizer |
| E.R. Squibb & Sons, L.L.C. | $168.43 | 2020-2023 | Eliquis, Camzyos |
| Akcea Therapeutics, INC. | $163.67 | 2020-2021 | |
| Regeneron Healthcare Solutions, INC. | $150.54 | 2019-2022 | |
| Abiomed | $84.03 | 2019 | |
| Althera Pharmaceuticals LLC | $80.18 | 2021 | |
| Arbor Pharmaceuticals, INC. | $73.94 | 2019-2021 | |
| Boston Scientific Corporation | $43.68 | 2019-2022 | |
| Itamar Medical INC | $37.46 | 2022 | |
| Merck Sharp & Dohme LLC | $26.02 | 2023 | Verquvo |
| Kiniksa Pharmaceuticals, LTD. | $25.42 | 2021-2022 | |
| Acist Medical Systems, INC. | $21.04 | 2023 | |
| Lundbeck LLC | $20.96 | 2020 | |
| Vital Connect, INC | $17.69 | 2023 | Vitalpatch Rtm |
| Bardy Diagnostics, INC. | $16.77 | 2022 | |
| Medtronic Vascular, INC. | $16.37 | 2019 | |
| Regeneron Pharmaceuticals, INC. | $16.20 | 2019 | |
| Preventice Services, LLC | $15.91 | 2021 | |
| Baxter Healthcare | $14.76 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Kowa Pharmaceuticals America, INC. | $14.39 | 2021 | |
| Amryt Pharma Holdings LTD | $12.59 | 2021 | |
| Getinge USA Sales, LLC | $11.88 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Terreson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.